Akiva Mintz, MD, PhD, is a physician-scientist whose translational research focuses on developing and personalizing cancer therapies using non-invasive molecular imaging. He obtained his medical and graduate degrees at the Pennsylvania State University College of Medicine where he helped discover and therapeutically exploit a new cancer restricted biomarker in malignant brain cancer. Dr. Mintz subsequently completed a Nuclear Medicine Residency and an NIH-sponsored molecular imaging fellowship at the University of Pennsylvania, where he developed novel preclinical multimodality imaging tools to non-invasively visualize disease and early response to therapy. Dr. Mintz is dual-board certified in Nuclear Medicine and Clinical Informatics. In addition to his medical training, Dr. Mintz is a CFA charterholder and completed a Masters in Healthcare Administration (MHA) at the University of North Carolina at Chapel Hill.

Dr. Mintz is a professor of radiology at Columbia University Irving Medical Center and an attending radiologist at NewYork-Presbyterian Hospital. He serves as vice chair of translational research for the Department of Radiology and is director of the Columbia University PET Center and division chief of the Division of Nuclear Medicine. Prior to Columbia, Dr. Mintz worked at Wake Forest, where he held a number of leadership roles, including vice chair of radiology and section head of nuclear medicine. Dr. Mintz was also the associate director of the Wake Forest Clinical and Translational Science Institute and co-leader of the Cancer Biology and Biochemistry Program of the NCI-designated Wake Forest Comprehensive Cancer Center.

Dr. Mintz's cross-translational research efforts exploit nuclear-based molecular imaging and therapy techniques to personalize anti-cancer therapies. His work is funded by multiple NIH grants and the American Cancer Society.